Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-006947
Filing Date
2021-06-04
Accepted
2021-06-04 13:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27671
2 filename2.txt TEXT-EXTRACT 1504
  Complete submission text file 0000000000-21-006947.txt   40232
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filed for) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations